385 related articles for article (PubMed ID: 23454054)
1. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
[TBL] [Abstract][Full Text] [Related]
2. Anti-solvent co-crystallization of carbamazepine and saccharin.
Wang IC; Lee MJ; Sim SJ; Kim WS; Chun NH; Choi GJ
Int J Pharm; 2013 Jun; 450(1-2):311-22. PubMed ID: 23598078
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
4. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process.
Zhang GC; Lin HL; Lin SY
J Pharm Biomed Anal; 2012 Jul; 66():162-9. PubMed ID: 22497855
[TBL] [Abstract][Full Text] [Related]
5. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
6. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
[TBL] [Abstract][Full Text] [Related]
7. A combinational supercritical CO2 system for nanoparticle preparation of indomethacin.
Tozuka Y; Miyazaki Y; Takeuchi H
Int J Pharm; 2010 Feb; 386(1-2):243-8. PubMed ID: 19895877
[TBL] [Abstract][Full Text] [Related]
8. In-line monitoring and interpretation of an indomethacin anti-solvent crystallization process by near-infrared spectroscopy (NIRS).
Lee HE; Lee MJ; Kim WS; Jeong MY; Cho YS; Choi GJ
Int J Pharm; 2011 Nov; 420(2):274-81. PubMed ID: 21907779
[TBL] [Abstract][Full Text] [Related]
9. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
10. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture.
Padrela L; de Azevedo EG; Velaga SP
Drug Dev Ind Pharm; 2012 Aug; 38(8):923-9. PubMed ID: 22092083
[TBL] [Abstract][Full Text] [Related]
11. Kinetics Study of Cocrystal Formation Between Indomethacin and Saccharin Using High-Shear Granulation With In Situ Raman Spectroscopy.
Tanaka R; Hattori Y; Ashizawa K; Otsuka M
J Pharm Sci; 2019 Oct; 108(10):3201-3208. PubMed ID: 31279736
[TBL] [Abstract][Full Text] [Related]
12. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
Alhalaweh A; Roy L; Rodríguez-Hornedo N; Velaga SP
Mol Pharm; 2012 Sep; 9(9):2605-12. PubMed ID: 22867056
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently?
Ferretti V; Dalpiaz A; Bertolasi V; Ferraro L; Beggiato S; Spizzo F; Spisni E; Pavan B
Mol Pharm; 2015 May; 12(5):1501-11. PubMed ID: 25794305
[TBL] [Abstract][Full Text] [Related]
14. Coamorphous repaglinide-saccharin with enhanced dissolution.
Gao Y; Liao J; Qi X; Zhang J
Int J Pharm; 2013 Jun; 450(1-2):290-5. PubMed ID: 23612357
[TBL] [Abstract][Full Text] [Related]
15. Influence of pH and method of crystallization on the solid physical form of indomethacin.
Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
[TBL] [Abstract][Full Text] [Related]
16. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
Sai Gouthami K; Kumar D; Thipparaboina R; Chavan RB; Shastri NR
Int J Pharm; 2015 Aug; 491(1-2):26-34. PubMed ID: 26068197
[TBL] [Abstract][Full Text] [Related]
17. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
18. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of supersaturation I: indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method.
Patel DD; Joguparthi V; Wang Z; Anderson BD
J Pharm Sci; 2011 Jul; 100(7):2623-41. PubMed ID: 21259238
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of indomethacin-saccharin cocrystals.
Jung MS; Kim JS; Kim MS; Alhalaweh A; Cho W; Hwang SJ; Velaga SP
J Pharm Pharmacol; 2010 Nov; 62(11):1560-8. PubMed ID: 21039541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
